Deerfield, IL, May 8, 2023 (Reuters) -- Baxter International Inc. has agreed to sell its biopharma solutions unit to a private-equity group for $4.25 billion, with the proceeds being used to pay down debt from its acquisition of Hill-Rom Holdings. This comes as medical device manufacturers struggle with supply-chain shortages and increased costs due to the pandemic.
Read full article here.
Boundless Bio Secures $100M Series C Funding to Advance ecDNA-Directed Therapies for Oncogene Cancer
San Diego, CA, May 16, 2023 (Business Wire) -- Boundless Bio, a pioneering precision oncology company, has successfully raised $100 million in a Series C financing round led by Leaps by Bayer and RA
Sunnyvale, CA, May 23, 2023 (Cepheid) -- Cepheid, a renowned molecular diagnostics company, has appointed Vitor Rocha as its new President. With over 20 years of experience in the medical devices in
Cambridge, MA, May 23, 2023 (Business Wire) -- ReNAgade Therapeutics, a cutting-edge company focused on harnessing the full potential of RNA medicines for disease correction, has successfully raised
